This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovative Contributions of Tabasum Sidi
Introduction
Tabasum Sidi is a notable inventor based in Jammu, India. He has made significant strides in the field of medicinal chemistry, particularly in the development of compounds for treating serious health conditions. His work focuses on innovative solutions that address critical medical challenges.
Latest Patents
Tabasum Sidi holds a patent for a novel chromone alkaloid known as dysoline, which is aimed at the treatment of cancer and inflammatory disorders. The patent describes a compound with the formula 5,7-dihydroxy-6-(3-hydroxy-1-methylpiperidin-4-yl)-2-methyl-4H-chromen-4-one. This compound has been identified as a potential inhibitor of cell growth and proliferation, as well as an inhibitor of pro-inflammatory cytokine production. The formulations derived from this compound can be utilized for effective treatment of cancer and inflammation.
Career Highlights
Tabasum Sidi is affiliated with the Council of Scientific and Industrial Research, where he contributes to groundbreaking research and development in the field of medicinal compounds. His dedication to innovation has led to advancements that could significantly impact healthcare.
Collaborations
Tabasum collaborates with esteemed colleagues, including Anamika Khajuria and Sunil Kumar Bhola. Their combined expertise fosters a productive research environment that enhances the potential for innovative discoveries.
Conclusion
Tabasum Sidi's contributions to medicinal chemistry, particularly through his patent on dysoline, highlight his commitment to addressing critical health issues. His work exemplifies the importance of innovation in the medical field, paving the way for future advancements.